Our mission is to change cancer into a chronic disease.
Athenex is a clinical stage biotechnology company focused on the development of autologous and allogeneic CAR-NKT cell therapies to treat cancers. Our goal is to become a global leader in bringing innovative cancer treatments to the market and improving health outcomes of cancer patients.
Athenex Pharma Solutions is an innovative global pharmaceutical company committed to researching, developing, manufacturing, and delivering the highest quality sterile injectable and compounded sterile 503B products in accordance with cGMP standards. Our quest for innovation brings unique presentations to the US market, and our commitment to excellence drives us to meet the highest possible standards.